Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Interventional Epidemiologic Research Studies To Reduce Mother-to-Child HIV-1 Transmission and Improve Infant Survival in Resource-Limited Countries of High HIV-1 Seroprevalence, Program Announcement 02074

---
identifier: "/us/fr/02-19512"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Interventional Epidemiologic Research Studies To Reduce Mother-to-Child HIV-1 Transmission and Improve Infant Survival in Resource-Limited Countries of High HIV-1 Seroprevalence, Program Announcement 02074"
title_number: 0
title_name: "Federal Register"
section_number: "02-19512"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Interventional Epidemiologic Research Studies To Reduce Mother-to-Child HIV-1 Transmission and Improve Infant Survival in Resource-Limited Countries of High HIV-1 Seroprevalence, Program Announcement 02074"
positive_law: false
currency: "2002-08-02"
last_updated: "2002-08-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-19512"
document_type: "notice"
publication_date: "2002-08-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "67 FR 50442"
fr_volume: 67
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Interventional Epidemiologic Research Studies To Reduce Mother-to-Child HIV-1 Transmission and Improve Infant Survival in Resource-Limited Countries of High HIV-1 Seroprevalence, Program Announcement 02074

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Interventional Epidemiologic Research Studies to Reduce Mother-to-Child HIV-1 Transmission and Improve Infant Survival in Resource-Limited Countries of High HIV-1 Seroprevalence, Program Announcement 02074.

*Times and Dates:* 9 a.m.-9:30 a.m., August, 28, 2002 (Open) 9:30 a.m.-4:30 p.m., August 28, 2002 (Closed).

*Place:* Double Tree Hotel, 3342 Peachtree Road, NE, Atlanta, GA.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to PA# 02074.

*Contact Person for More Information:* Beth Wolfe, Prevention Support Office, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road NE MS E-07, Atlanta, Georgia 30333, 404-639-8025.

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: July 29, 2002.

John Burckhardt,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).